In combination with the result that NKp46−ILC3 rather NKp46+ILC3 in the BPD group were significantly increased compared with the control group, we suggested that NKp46−ILC3 can aggravate the inflammation of BPD by secreting IL-17. This evidence concerns the gene IL17A and bronchopulmonary dysplasia.